Nutritional status of hemodialysis patients with secondary hyperparathyroidism

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 11, 2000, Pages 1305-1311

  Rezende, L T T ^a   Cuppari, L ^a   Carvalho, A B ^a   Canziani, M E F ^a   Manfredi, S R ^a   Cendoroglo, M ^a   Sigulem, D M ^a   Draibe, S A ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b 960   (Brazil)

Author keywords

Chronic renal failure; Nutritional assessment; Parathormone; Secondary hyperparathyroidism

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; FEMALE; HUMAN; MALE; NONPARAMETRIC TEST; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; SECONDARY HYPERPARATHYROIDISM;

ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; NUTRITIONAL STATUS; PARATHYROID HORMONE; STATISTICS, NONPARAMETRIC;

EID: 0034327604     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000001100007     Document Type: Article

References (37)

1. Bergström J & Lindholm B (1993). Nutrition and adequacy of dialysis: How do hemodialysis and CAPD compare? Kidney International, 43 (Suppl 40): 39-50.
2. Cuppari L, Medeiros FAM, Pappini HF, Cendorolo Neto M, Canziani MEF, Martini L, Ajzen H & Draibe SA (1994). Effectiveness of oral energy-protein supplementation in severely malnourished hemodialysis patients. Journal of Renal Nutrition, 4 (Suppl 3): 127-135.
3. Degoulet P, Reach L, A'mé F, Rioux P, Jacobs C & Legrain M (1980). Risk factors in chronic hemodialysis. Proceedings of the European Dialysis and Transplant Association, 17: 149-154.
4. Lowrie EG & Lew NL (1990). Death risk in hemodialysis patients: the predictive values of commonly measured variables and an evaluation of death rate differences between facilities. American Journal of Kidney Diseases, 15 (Suppl 5): 458-482.
5. Acchiardo SR, Moore LW & Latour PA (1983). Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney International, 24 (Suppl 16): 199-203.
6. Cuppari L, Draibe AS, Anção MS, Sigulem D, Sustovic DR, Ajzen H & Ramos OL (1989). Avaliação nutricional de pacientes renais crônicos em programa de hemodiálise. Estudo multicêntrico. Revista da Associação Médica Brasileira, 35 (Suppl 1): 9-14.
7. Shoenfeld P, Henry RR, Laird NM & Roxe DM (1983). Assessment of nutritional status of the national cooperative dialysis study population. Kidney International, 23 (Suppl 13): 80-88.
8. Kopple JD, Swendseid ME, Shinaberger JH & Umezawa CY (1973). The free and bound amino acids removed by hemodialysis. Transactions of the American Society for Artificial Internal Organs, 19: 309-313.
9. Gutierrez A, Alvestrand A, Wahren J & Bergstrom J (1990). Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney International, 38: 487-494.
10. Bergström J (1995). Why are dialysis patients malnourished? American Journal of Kidney Diseases, 26 (Suppl 1): 229-241.
11. Mitch WE, Medina R, Grieber S, May RC, England BK, Price SR, Bailey JL & Goldberg AL (1994). Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. Journal of Clinical Investigation, 93: 2127-2133.
12. Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A & DeFronzo RA (1985). Role of parathyroid hormone in the glucose intolerance of chronic renal failure. Journal of Clinical Investigation, 75: 1037-1044.
13. Luger A, Kovarik J & Stummvoll HK (1987). Blood-membrane interaction in hemodialysis leads to increased cytokine production. Kidney International, 32: 84-88.
14. Eknoyan G (1988). Effects of renal insufficiency on nutrient metabolism and endocrine function. In: Mitch WE & Klahr S (Editors), Nutrition and the Kidney. Little Brown and Company, Boston/Toronto, 29-58.
15. Frame B, Heinze Jr EG, Block MA & Manson GA (1968). Myopathy in primary hyperparathyroidism. Annals of Internal Medicine, 68: 1022-1027
16. Patten BM, Bilezikian JP, Mallete LE, Prince A, Engel WK & Aurbach GH (1974). Neuromuscular disease in primary hyperparathyroidism. Annals of Internal Medicine, 80: 182-193.
17. Kopple JD, Cianciaruso B & Massry SG (1980). Does parathyroid hormone cause protein wasting? Contributions to Nephrology, 20: 138-148.
18. Garber AJ (1983). Effect of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. Journal of Clinical Investigation, 71: 1806-1821.
19. Wassner SJ & Li JB (1987). Lack of an acute effect of parathyroid hormone within skeletal muscle. International Journal of Pediatric Nephrology, 8: 15-20.
20. Quarles DL, Lobaugh B & Murphy G (1992). Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. Journal of Clinical Endocrinology and Metabolism, 75: 145-150.
21. Torres A, Lorenzo V, Hernández D, Rodríguez JC, Concéption MT, Rodríguez AP, Hernandez A, De Bonis E, Darias E, Gonzáles-Posada JM, Losada M, Rufino M, Felsenfeld AJ & Rodríguez M (1995). Bone disease in predialysis, hemodialysis, and CARD patients: Evidence of a better bone response to PTH. Kidney International, 47: 1434-1442.
22. Keys A, Fidanza F & Kcarvonen MJ (1972). Indices of relative weight and obesity. Journal of Chronic Diseases, 25: 329-343.
23. Durnin JV & Wormersley J (1974). Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. British Journal of Nutrition, 32: 77-97.
24. Frisancho AR (1981). New norms of upper limb fat and muscle areas for assessment of nutritional status. American Journal of Clinical Nutrition, 34: 2540-2545.
25. United States of America. Department of Agriculture (1963). Human Nutrition Information Service: Composition of Foods. Raw, Processed, Prepared Agriculture Handbook No. 8, Series 1-16. Revised 1976-1986.
26. Sargent JA & Gotch AS (1979). Mass balance: a quantitative guide to clinical nutritional therapy. Journal of the American Dietetic Association, 75: 547-555
27. Vieira JG, Kasamatsu TS, Amarante EC & Kunii IS (1994). Development and clinical application of an immunofluorometric assay for intact parathyroid hormone. Brazilian Journal of Medical and Biological Research, 27: 2379-2382.
28. Jindal KK, Manuel A & Goldstein MB (1989). Percent reduction in blood urea concentration during hemodialysis (PRU): a simple and accurate method to estimate Kt/V urea. Transactions of the American Society for Artificial Internal Organs, 12: 411-419.
29. Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw AS & Kopple JD (1989). Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney International, 35: 704-711.
30. Ikizler TA, Greene J, Wingard RT, Parker PA & Hakin RM (1995). Spontaneous dietary protein intake during progression of chronic renal failure. Journal of the American Society of Nephrology, 6: 1386-1391.
31. Basiotis PP, Welsh SO & Cronin FJ (1987). Number of days of food intake records required to estimate individual and group nutrient intakes with defined confidence. Journal of Nutrition, 117 (Suppl 9): 1638-1641.
32. Feinfeld DA (1992). The role of parathyroid hormone as a uremic toxin: current concepts. Seminars in Dialysis, 5 (Suppl 1): 48-53.
33. Kronemberg HM (1993). Parathyrod hormone: mechanism of action. In: Favus MJ (Editor), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Lippincott-Raven, Philadelphia, 58-60.
34. Goldstein DA, Chui LA & Massry SG (1978). Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. Journal of Clinical Investigation, 62: 88-93.
35. Schluter KD & Piper HM (1998). Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovascular Research, 37 (Suppl 1): 34-41.
36. Smogorzewiski M, Piskorska G, Borum PR & Massry SG (1988). Chronic renal failure, parathyroid hormone and fatty acids oxidation in skeletal muscle. Kidney International, 33: 555-560.
37. Vanholder R, Van Biessen W & Ringoir S (1993). Contributing factors to the inhibition of phagocytosis in hemodialyzed patients. Kidney International, 44: 208-214.